Get the Stockscreener App
68.04
0.60%
-0.41
Pre-market:
66.80
-1.24
-1.82%
Corcept Therapeutics Inc Stock (CORT) Latest News
abrdn plc Reduces Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Boston Trust Walden Corp Lowers Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Endogenous Cushing's Syndrome Market Statistics Expected - openPR
Corcept Therapeutics stock soars to all-time high of $70.78 - MSN
Market Recap Check: Corcept Therapeutics Inc (CORT)’s Positive Finish at 68.45, Up/Down 2.30 - The Dwinnex
Are Corcept Therapeutics Inc’shares a good deal? - US Post News
Investing in Corcept Therapeutics Inc (CORT): What You Must Know - Knox Daily
Calamos Advisors LLC Sells 4,908 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
KBC Group NV Acquires 1,296 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Q1 EPS Forecast for Corcept Therapeutics Lifted by Analyst - MarketBeat
Pacer Advisors Inc. Purchases 1,689 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Exchange Traded Concepts LLC Cuts Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Shares Down 5%Here's What Happened - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Hits New 1-Year High Following Analyst Upgrade - MarketBeat
Blue Trust Inc. Buys 5,567 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol - Yahoo Finance
Synergy Asset Management LLC Increases Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Q1 EPS Estimate for Corcept Therapeutics Boosted by Analyst - MarketBeat
Corcept (CORT) Soars 13.6%: Is Further Upside Left in the Stock? - MSN
SG Americas Securities LLC Has $564,000 Stake in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Canaccord Genuity Group Forecasts Strong Price Appreciation for Corcept Therapeutics (NASDAQ:CORT) Stock - Defense World
Corcept Therapeutics stock soars to all-time high of $70.78 By Investing.com - Investing.com Australia
Corcept Therapeutics (NASDAQ:CORT) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - MarketBeat
5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era - Yahoo Finance
Metabolic Dysfunction-Associated Steatohepatitis Market to Register Stunning Growth at a CAGR of 17.9% in the US by 2034 | DelveInsight - Yahoo Finance
All You Need to Know About Corcept (CORT) Rating Upgrade to Strong Buy - MSN
Canaccord raises Corcept stock target to $130 on robust outlook By Investing.com - Investing.com Canada
Zacks.com featured highlights include OppFi, Corcept Therapeutics, DXP Enterprises, Perpetua Resources and Graham - Yahoo Finance
Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives $65.25 Consensus Price Target from Analysts - Defense World
Corcept Therapeutics Incorporated (CORT) Hit a 52 Week High, Can the Run Continue? - MSN
Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Inspire Investing LLC Takes $807,000 Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
Zacks Research Issues Pessimistic Outlook for CORT Earnings - Defense World
Is Corcept (CORT) a Solid Growth Stock? 3 Reasons to Think "Yes" - MSN
Corcept Therapeutics (NASDAQ:CORT) Hits New 1-Year HighWhat's Next? - MarketBeat
Corcept Therapeutics stock soars to all-time high of $62.34 - MSN
Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm - PR Newswire
Zacks Research Issues Negative Estimate for CORT Earnings - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 4.4%Should You Sell? - MarketBeat
Corcept Therapeutics stock soars to all-time high of $62.34 By Investing.com - Investing.com Australia
Zacks Research Has Bullish Estimate for CORT Q4 Earnings - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Trading Up 7.9%Here's What Happened - MarketBeat
Corcept Therapeutics Generating Strong Revenue And Profit Growth (NASDAQ:CORT) - Seeking Alpha
Cushing's Syndrome Market Expected to Hit US$ 291.1 million - openPR
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):